Peptides DB
Research-centric peptide and protocol reference hub
Study 21 of 30Glutathione (GSH) literatureJournal of ethnopharmacology · Observational2027

UHPLC-MS/MS and GC-MS screening of Synedrella nodiflora (L.) Gaertn. and its remedial effect in carbon tetrachloride (CCl(4))-induced HepG2 cells against oxidative stress and apoptosis.

Synedrella nodiflora showed statistically significant effects in reducing markers of oxidative stress in HepG2 cells, but clinical implications in humans remain unclear.

Read at Journal of ethnopharmacologyAdd to compare

Where it sits

this study against the rest of the glutathione (gsh) corpus
1
Preclinical
23
Observational · this one
0
Open-label
3
Randomised
3
Reviews

Summary and findings

This study investigated the remedial effects of Synedrella nodiflora on carbon tetrachloride (CCl4)-induced oxidative stress and apoptosis in human HepG2 cells. The aqueous extract was tested at concentrations ranging from 0 to 100 μg/mL. The results indicated improvements in cell viability and reductions in oxidative stress markers.

How much of this paper we could read: full text read (0.70). We had a clear abstract, so the summary below closely tracks the paper. What this means →
p<0.01 reduction in caspase 3 activity in CCl4-induced HepG2 cells upon treatment with S. nodiflora.2027

Abstract

The authors’ words, as Journal of ethnopharmacology supplied them

<h4>Ethnopharmacological relevance</h4>Synedrella nodiflora (L.) Gaertn. is known for its medicinal properties in Malaysian traditional practice. Our previous study reported the prophylactic effect of S. nodiflora in protecting carbon tetrachloride (CCl<sub>4</sub>)-induced hepatic injury in rats. This study aimed to identify the potential bioactive compounds in the same aqueous extract of S. nodiflora and to determine its remedial effect against CCl<sub>4</sub>-induced oxidative stress and apoptosis in human HepG2 cells.<h4>Materials and methods</h4>Aqueous extract of S. nodiflora used in the previous prophylactic study was characterized using UHPLC-MS/MS and GC-MS to screen the extended phytochemical profile. HepG2 cells were exposed to CCl<sub>4</sub> and post-treated with S. nodiflora (0-100 μg/mL) to determine the efficacy of the extract in repairing the damage, unlike the previous preventive study.<h4>Results</h4>The results of UHPLC-MS/MS of S. nodiflora aqueous extract showed putative annotations of glycosides, flavonoids, phenolics, terpenoids, and vitamins among the major phytochemicals present. The in vitro results exhibited improved HepG2 cell viability and reduced cellular ROS levels with increasing concentrations of S. nodiflora against CCl<sub>4</sub>. The concentration of cytochrome C release and caspase 3 activity were reduced (p < 0.01) in CCl<sub>4</sub>-induced HepG2 cells upon treatment with S. nodiflora. The activity of antioxidant enzyme superoxide dismutase (SOD) and reduced glutathione (GSH) levels were improved (p < 0.01) whereas malondialdehyde (MDA) levels were reduced (p < 0.01) by S. nodiflora in CCl<sub>4</sub>-induced HepG2 cells. The levels of inflammatory cytokines TNF-α, IL-8, and IL-1β were suppressed in CCl<sub>4</sub>-induced HepG2 cells by S. nodiflora.<h4>Conclusion</h4>The findings suggest that the putatively annotated bioactive compounds of S. nodiflora may have reversed the oxidative stress and apoptosis induced by CCl<sub>4</sub> in HepG2 cells.

Background

Not reported in abstract.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Limitations

Not reported in abstract.

Elsewhere in the Glutathione (GSH) corpus

BEffectiveness of Simulation-based Training on Emergency Response Knowledge Among Inter-Professional Staff Involved in Gastrointestinal Endoscopic Practice.DEN open · 2026 · n=22 · Correct chest compression improved, p < 0.01.HumanDIntermittent fasting to treat diabetes: time to update clinical practice guidelines.The lancet. Diabetes & endocrinology · 2026 · HbA1c reduction typically by 0·3-1·2%.reviewAHuman versus analogue insulin for children and young adults with type 1 diabetes in low-resource settings (HumAn-1): a multicentre, open-label, randomised controlled trial.The lancet. Diabetes & endocrinology · 2026 · Adjusted mean difference for time in very low range was 0.22% (97.5% CI -0.83 to 1.27, p=0.63).HumanCDietary tropical seaweed supplementation modulates antioxidant status and immune response in adult Labrador Dogsbiorxiv-preprint · 2026 · Serum cortisol concentrations were significantly lower in the GS and TC groups than in the control (P<0.05).AnimalCLow-temperature induced neuro-oxidative stress and metabolic reprogramming in the brain of juvenile fourfinger threadfin (Eleutheronema tetradactylum)biorxiv-preprint · 2026 · MDA levels significantly surged by day 14, indicating severe late-stage lipid peroxidation.AnimalCGALNT2-mediated O-GalNAcylation of METTL3 promotes radioresistance in esophageal squamous cell carcinoma by stabilizing GPX4 mRNA via m6A modificationbiorxiv-preprint · 2026 · Not reported in abstract.Animal